Emergence of resistance to beta-lactams, aminoglycosides, and quinolones during combination therapy for infection due to Serratia marcescens

J Infect Dis. 1986 Mar;153(3):617-9. doi: 10.1093/infdis/153.3.617.
No abstract available

MeSH terms

  • Aminoglycosides / therapeutic use
  • Anti-Bacterial Agents / therapeutic use*
  • Bacterial Infections / drug therapy*
  • Bacterial Proteins / analysis
  • Drug Resistance, Microbial
  • Drug Therapy, Combination
  • Humans
  • Membrane Proteins / analysis
  • Molecular Weight
  • Serratia marcescens / drug effects*
  • beta-Lactams / therapeutic use*

Substances

  • Aminoglycosides
  • Anti-Bacterial Agents
  • Bacterial Proteins
  • Membrane Proteins
  • beta-Lactams